Similar articles for PMID: 32934035

Year	Number of Results
1969	1
1975	1
1986	1
1993	1
1996	1
1998	1
2002	1
2003	1
2006	1
2007	1
2008	3
2009	2
2011	2
2012	2
2013	4
2014	5
2015	6
2016	9
2017	9
2018	17
2019	12
2020	3
2021	1
2024	0

1

Research in brief: Serum urate reduction and its effect on the progression of chronic kidney disease.

Pooni RS, Corbett R. Pooni RS, et al. Clin Med (Lond). 2020 Sep;20(5):448. doi: 10.7861/clinmed.rib.20.5.1. Clin Med (Lond). 2020. PMID: 32934035 Free PMC article. No abstract available.

2

Urate-Lowering Therapy and Chronic Kidney Disease Progression.

Feig DI. Feig DI. N Engl J Med. 2020 Jun 25;382(26):2567-2568. doi: 10.1056/NEJMe2015886. N Engl J Med. 2020. PMID: 32579818 No abstract available.

3

Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients.

Chung TT, Yu KH, Kuo CF, Luo SF, Chiou MJ, Lan WC, Chen JS, Tseng WY, Hsieh AH, Wang LC. Chung TT, et al. Arthritis Res Ther. 2019 Sep 18;21(1):210. doi: 10.1186/s13075-019-1993-9. Arthritis Res Ther. 2019. PMID: 31533805 Free PMC article.

4

The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trial.

Stamp LK, Chapman PT, Barclay M, Horne A, Frampton C, Tan P, Drake J, Dalbeth N. Stamp LK, et al. Arthritis Res Ther. 2017 Dec 21;19(1):283. doi: 10.1186/s13075-017-1491-x. Arthritis Res Ther. 2017. PMID: 29268756 Free PMC article. Clinical Trial.

5

Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.

Panomvana D, Sripradit S, Angthararak S. Panomvana D, et al. J Clin Rheumatol. 2008 Feb;14(1):6-11. doi: 10.1097/RHU.0b013e318164dceb. J Clin Rheumatol. 2008. PMID: 18431090 Clinical Trial.

6

Allopurinol and kidney function: An update.

Stamp LK, Chapman PT, Palmer SC. Stamp LK, et al. Joint Bone Spine. 2016 Jan;83(1):19-24. doi: 10.1016/j.jbspin.2015.03.013. Epub 2015 Oct 6. Joint Bone Spine. 2016. PMID: 26453097 Review.

7

Low-Dose Allopurinol Promotes Greater Serum Urate Lowering in Gout Patients with Chronic Kidney Disease Compared with Normal Kidney Function.

Toprover M, Crittenden DB, Modjinou DV, Oh C, Krasnokutsky S, Fisher MC, Keenan RT, Pillinger MH. Toprover M, et al. Bull Hosp Jt Dis (2013). 2019 Mar;77(2):87-91. Bull Hosp Jt Dis (2013). 2019. PMID: 31140959

8

Major unanswered questions in the clinical gout field.

Stamp LK. Stamp LK. Curr Opin Rheumatol. 2017 Mar;29(2):171-177. doi: 10.1097/BOR.0000000000000367. Curr Opin Rheumatol. 2017. PMID: 27926541 Review.

9

Allopurinol Against Progression of Chronic Kidney Disease.

Golmohammadi S, Almasi A, Manouchehri M, Omrani HR, Zandkarimi MR. Golmohammadi S, et al. Iran J Kidney Dis. 2017 Jul;11(4):286-293. Iran J Kidney Dis. 2017. PMID: 28794291 Free article. Clinical Trial.

10

[Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy].

Eliseev MS, Novikova AM. Eliseev MS, et al. Ter Arkh. 2019 May 15;91(5):120-128. doi: 10.26442/00403660.2019.05.000232. Ter Arkh. 2019. PMID: 32598686 Russian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

79 results

Results by year